Portal fibroblasts: Underappreciated mediators of biliary fibrosis†

Dranoff, Jonathan A., Wells, Rebecca G.·2010·Hepatology

Cited by (273)

Items 201–273 of 273

  1. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer
    Luohang Ni, Jianing Xu, Quanpeng Li, Xianxiu Ge, Fei Wang, Xueting Deng, Lin Miao · 2024 · Cancer Management and Research
  2. An overview of recent treatment options for primary sclerosing cholangitis
    Ioanna Mousavere · 2023 · Annals of Gastroenterology
  3. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities
    Rimpy Diwan, Samantha L. Gaytan, Himanshu Narendrakumar Bhatt, Jaqueline Pena‐Zacarias, Md Nurunnabi · 2024 · Drug Delivery and Translational Research
  4. Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis
    Prithvi Reddy Akepati, Eric M. Gochanour · 2024 · Expert Opinion on Investigational Drugs
  5. EMT in Liver Fibrosis
    Viktor Sterzer, Muhammad Alsamman, T. Bretag, David Scholten · 2014 · Current Pathobiology Reports
  6. Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12
    Yedidya Saiman, Tatsuki Sugiyama, Noa Simchoni, Carlo Spirlı̀, Meena B. Bansal · 2015 · American Journal Of Pathology
  7. Epigenetic Mechanisms of Pancreatobiliary Fibrosis
    Sayed Obaidullah Aseem, Robert C. Huebert · 2019 · Current Treatment Options in Gastroenterology
  8. Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct
    Taotao Zhou, Katja Bartelheimer, Fabian Ruping, Christian Rupp, Peter Sauer, Ronald Koschny, Arianeb Mehrabi, Markus Mieth, Rebecca von Haken, Karl Heinz Weiss et al. · 2019 · European Journal of Gastroenterology & Hepatology
  9. Stellate Cells and Fibrosis
    Youngmin A. Lee, Scott L. Friedman · 2020 · Wiley eBooks
  10. Portal fibroblasts: A renewable source of liver myofibroblasts
    Steven P. O’Hara, Nicholas F. LaRusso · 2022 · Hepatology
  11. Genetic Loss of HIF-Prolyl-Hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis
    Christopher Tuffs, Mareen Dupovac, Katrin Richter, Sophia Holten, Thomas Schaschinger, Oliver Marg, Adisa Poljo, Ayse nur Tasdemir, Jonathan M. Harnoss, Adrian Theophil Billeter et al. · 2024 · American Journal Of Pathology
  12. Myofibroblasts in Normal and Fibrotic Liver in Different Animal Species
    Vladimir Kukolj · 2014 · Acta veterinaria
  13. Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective
    Yuanxin Liang, Grace Liejun Guo, Lanjing Zhang · 2022 · Gene Expression
  14. The role of mesenchymal cells in cholangiocarcinoma
    Mireia Sueca-Comes, Elena Cristina Rusu, J. Ashworth, Pamela Collier, Catherine Probert, Alison Ritchie, Marian L. Meakin, Nigel Patrick Mongan, Isioma U. Egbuniwe, Jesper Bøje Andersen et al. · 2024 · Disease Models & Mechanisms
  15. Beyond scar formation: Portal myofibroblast‐mediated angiogenesis in the fibrotic liver
    Michel Fausther, Jonathan A. Dranoff · 2014 · Hepatology
  16. Mechanisms of Fibrosis in Primary Biliary Cholangitis
    Ling Wu, Jia Ding, Ning‐Ping Zhang, Feng Li, Xiuping Liu, Jian Wu · 2020 · Current Hepatology Reports
  17. Oxidative Stress and Liver Fibrogenesis
    Erica Novo, Fabio Marra, Maurizio Parola · 2015 · Oxidative stress in applied basic research and clinical practice
  18. Novel perspectives on the origins of the hepatic myofibroblasts
    Tatiana Kisseleva, Jun Xu, Xiao Liu, David A. Brenner · 2015 · Cell Health and Cytoskeleton
  19. Liver portal fibroblasts induce the functions of primary human hepatocytes in vitro
    Grace E. Brown, Vedant V Bodke, Brenton R. Ware, Salman R. Khetani · 2025 · Communications Biology
  20. Application of artificial intelligence in liver diseases: From diagnosis to treatment
    Qiong Li, Junfeng Li, Xiaorong Mao · 2021 · Artificial Intelligence in Gastroenterology
  21. Current trends and future perspectives in the treatment of PBC and PSC: A review
    Debashree Debasish Das, Nikita Sharma, Pooja A. Chawla · 2022 · Health Sciences Review
  22. Structure, Function and Responses to Injury
    James M. Crawford, Paulette Bioulac‐Sage, Prodromos Hytiroglou · 2023 · Elsevier eBooks
  23. Bile Formation and Cholestasis
    Heidi Eigenrauch Karpen, Saul J. Karpen · 2011 · Elsevier eBooks
  24. CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESIS
    Elena Ivanovna Lebedeva, O. D. Myadelets · 2019 · Hepatology and Gastroenterology
  25. Hepatic Fibrosis and Cirrhosis
    Don C. Rockey · 2014 · Elsevier eBooks
  26. Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
    Edward L. LeCluyse, Leah M. Norona, James A. Akingbasote, Lawrence S. Howell, Jeffrey L. Woodhead, M.J. Cross, Adrian B. Roth, Christopher E. Goldring · 2017 · Elsevier eBooks
  27. Targeting Fibroblasts in Fibrosis and Cancer
    Ahmed M. R. H. Mostafa, Ruchi Bansal, Jai Prakash · 2020 · Royal Society of Chemistry eBooks
  28. Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
    Gokcen Tufan Ayse, Gözde Derviş Hakim, Harun Akar, Mesut Akarsu · 2020 · Hepatology forum/Hepatology forum (Online)
  29. Anatomy and histopathology of the liver
    James M. Crawford · 2024 · Elsevier eBooks
  30. The Role of the Tumor Microenvironment in the Pathogenesis of Cholangiocarcinoma
    Matthew A. Quinn, Matthew McMillin, Gabriel A. Frampton, Syeda Humayra, Li Huang, Sharon DeMorrow · 2012 · InTech eBooks
  31. Cholangiocellular Cholangiocellular carcinoma today. Literature review
    Д. Л. Ротин · 2015 · Malignant tumours
  32. Hepatic Fibrosis and Cirrhosis
    Rebecca G. Wells · 2010 · Molecular pathology library
  33. Beneficial effect of 4-Methylumbelliferone against bile duct ligation-induced hepatic fibrosis in rats
    Naoya Sawada, Kenichiro Mikami, Go Igarashi, Tetsu Endo, Ken Sato, Ikuko Kakizaki, Shinsaku Fukuda · 2016 · Institutional Repositories DataBase (IRDB)
  34. Experimental Workflow for Preclinical Studies of Human Antifibrotic Therapies
    Lien Reolizo, Michitaka Matsuda, Ekihiro Seki · 2023 · Methods in molecular biology
  35. Portal Fibroblast Role in Liver Fibrosis in Rats
    Suzan B. S. Abdu, Fatima Motlag Al- · 2018 · International Journal of Pharmacology
  36. Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
    Jessica W. Wen, Abby L. Olsen, Maryna Perepelyuk, Rebecca G. Wells · 2012 · Journal of Visualized Experiments
  37. New Insights in the Roadmap of Liver Fibrosis Pathogenesis
    Eman G El-Ahwany, Mona K. Zoheiry · 2014 · The Egyptian Journal of Hospital Medicine
  38. Distribution of hepatic stellate cells and their role in the development of parasitic fibrosis and liver cirrhosis in domestic animals
    Vladimir Kukolj, Slađan Nešić, Ivana Vučićević · 2015 · Veterinarski glasnik
  39. Immunopathology of the Hepatobiliary System
    Danielle L. Brown · 2017 · Molecular and integrative toxicology
  40. Pathomorphology of liver fibrosis in trepanobioptates of patients with steatohepatitis: main types, sources of development, features of progression
    V. A. Tumanskiy, С. В. Фень · 2017 · Pathologia
  41. Hepatic Myofibroblasts in Liver Fibrogenesis
    Chiara Busletta, Erica Novo, Stefania Cannito, Claudia Paternostro, Maurizio Parol · 2012 · InTech eBooks
  42. Mechanisms of Proinflammatory Signaling during Cholestasis
    Katryn Miller Allen · 2011
  43. Hepatic Fibrosis
    Scott L. Friedman · 2011 · Wiley eBooks
  44. PDE4 inhibition: a novel therapeutic strategy in liver fibrosis.
    Mohamed Elnagdy · 2021
  45. Liver cell types derived from pluripotent stem cells
    Sean Philip Harrison · 2014 · Research Explorer (The University of Manchester)
  46. Reversal of Liver Fibrosis: A Review
    Henadak Mona · 2011 · InTech eBooks
  47. Role of Coagulation in Xenobiotic-Induced Liver Injury
    Bradley P. Sullivan · 2012 · KU ScholarWorks (The University of Kansas)
  48. Adult Liver Stem Cells
    Francesco Paolo Russo, Patrizia Burra, Maurizio Parola · 2013 · Stem cell biology and regenerative medicine
  49. Strategies in secondary biliary fibrosis
    José Manuel Hermosillo‐Sandoval, Adolfo Daniel Rodríguez-Carrizález, Alejandra Guillermina Miranda‐Díaz · 2013 · Journal of Biomedical Science and Engineering
  50. AVALIAÇÃO DE CITOCINAS NA FIBROSE HEPÁTICA INDUZIDA EM RATOS PELA LIGADURA DO DUCTO BILIAR
    Juliana Saraiva Freitas, Amanda Birindeli Alkmin, Luciana Barros Sant’Anna, Maria Angélica Gargione Cardoso · 2015 · Revista Univap
  51. Hepatocyte Apoptosis at the Interplay of Intracellular Organelles and Membrane-Bound Receptors: Targets for Therapy
    Golnar Karimian, Klaas Nico Faber · 2012 · Clinical and Experimental Pharmacology
  52. Expression of aVB6 integrin by Pkhd1-defective cholangiocytes links enhanced ductal secretion of Macrophage chemokines to progressive portal fibrosis in Congenital Hepatic Fibrosis
    Luca Locatelli · 2013 · BOA (University of Milano-Bicocca)
  53. Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture
    Aygul K. Shafigullina, Olja Mijanović, Reshad Akbor Prottoy, M. N Zhuravleva, Marina O. Gomzikova, Anisa Azatovna Gumerova, Albert Anatolyevich Rizvanov, Andrey Pavlovich Kiyasov · 2017 · BioNanoScience
  54. Enhancer of zeste homolog 2 (EZH2) gene inhibition via 3-Deazaneplanocin A (DZNep) in human liver cells and it is relation with fibrosis
    Merve Özel, İlker Güven, Eser Kılıç, Munis Dündar, Gülden Başkol · 2020 · Turkish Journal of Biochemistry
  55. Fibrose hépatique
    Sara Lemoinne, Axelle Cadoret, Nelly Bosselut, Chantal Housset, Dominique Wendum, Dominique Thabut · 2012 · EMC - Hépatologie
  56. Tumor-asszociált miofibroblasztok genetikai, epigenetikai, transzkripciós és funkcionális jellemzői
    Ildikó Huliák · 2021
  57. Biliary Cirrhosis
    Jonathan A. Dranoff · 2010 · Molecular pathology library
  58. Fibrosis induced by chronic cholestatic diseases
    Pablo Muriel · 2022 · Elsevier eBooks
  59. Peer Review #3 of "Hypoxia-induced factor and its role in liver fibrosis (v0.1)"
    2022 · PeerJ
  60. Peer Review #2 of "Hypoxia-induced factor and its role in liver fibrosis (v0.1)"
    2022 · PeerJ
  61. Peer Review #1 of "Hypoxia-induced factor and its role in liver fibrosis (v0.2)"
    2022 · PeerJ
  62. Peer Review #1 of "Hypoxia-induced factor and its role in liver fibrosis (v0.1)"
    2022 · PeerJ
  63. Peer Review #3 of "Hypoxia-induced factor and its role in liver fibrosis (v0.2)"
    2022 · PeerJ
  64. Peer Review #2 of "Hypoxia-induced factor and its role in liver fibrosis (v0.2)"
    2022 · PeerJ
  65. Characterization of rat myofibroblasts isolated from liver portal tracts using explantation technique
    О. Миянович, M N Katina, Albert Anatolyevich Rizvanov, A. P Kiyasov · 2013 · Genes and Cells
  66. Rôle direct du virus de l'hépatite C dans fibrogenèse hépatique et les mécanismes asociés
    Alexandre Florimond · 2014
  67. Rôle du récepteur purinergique P2X4 dans l'activation des myofibroblastes au cours de la fibrogenèse hépatique
    Camille Le Guilcher · 2018 · theses.fr (ABES)
  68. Identification of portal mesenchymal stem cells and derived myofibroblasts in liver fibrosis
    Lin Lei · 2020 · HAL
  69. Role of the protein ADAMTS12 in the progression of Chronic Liver Diseases
    Fida Azar · 2021
  70. Application of functional genomics to colorectal cancer liver metastases and blastic plasmacytoid dendritic cell neoplasms
    Ambre Giguelay · 2021
  71. Advancing liver disease treatment: The promise of phytotherapy and hepatic stellate cell modulation
    Nabanita Chatterjee, Sathish Kumar Mungamuri · 2025 · Journal of Clinical and Experimental Gastroenterology
  72. Anti-oxidant, anti-inflammatory and anti fibrotic effect of Thiosemicarbazide derivatives on CCl4 induced liver fibrosis
    Aneeqa Mehtab, Amjad Ali, Irum Mushtaq, Arouba Fatima, Kasim Sakran Abass, Khalid Jamaan Alzahrani, Muhammad Shafique, Johar Jamil, Yi Chen, Hamid Ali · 2026 · Results in Chemistry
  73. Biliary atresia-related liver fibrosis
    Tao Zhou, Fang Wang, Pengpeng Sun, Meng Kong · 2026 · Frontiers in Cell and Developmental Biology